MacroGenics reported $265.3M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 384.69B 19.14B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Genmab DKK 20.48B 1.02B Dec/2025
Geron USD 955M 112M Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Karyopharm Therapeutics USD 1.05B 912M Jun/2026
Merck USD 297.1B 35.84B Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Xencor USD 893M 200M Mar/2026